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SUMMARY
Typhoid fever caused by Salmonella enterica serovar (S.) Typhi differs in its clinical presentation 
from gastroenteritis caused by S. Typhimurium and other non-typhoidal Salmonella serovars. The 
different clinical presentations are attributed in part to the virulence-associated capsular 
polysaccharide (Vi antigen) of S. Typhi, which prevents phagocytes from triggering a respiratory 
burst by preventing antibody-mediated complement activation. Paradoxically, the Vi antigen is 
absent from S. Paratyphi A, which causes a disease that is indistinguishable from typhoid fever. 
Here, we show that evasion of the phagocyte respiratory burst by S. Paratyphi A required very 
long O antigen chains containing the O2 antigen to inhibit antibody binding. We conclude that the 
ability to avoid the phagocyte respiratory burst is a property distinguishing typhoidal from non-
typhoidal Salmonella serovars that was acquired by S. Typhi and S. Paratyphi A independently 
through convergent evolution.
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INTRODUCTION
Typhoid fever, caused by the human-adapted Salmonella enterica serovar (S.) Typhi, is a 
major human disease that is responsible for 21.6 million illnesses annually, whereas 
paratyphoid fever, associated predominantly with the human-adapted S. Paratyphi A, is 
responsible for 5.4 million cases per year (Crump et al., 2004). Typhoid and paratyphoid 
fever are indistinguishable in their clinical signs and symptoms (Nuccio et al., 2013), 
suggesting that typhoidal Salmonella serovars possess similar virulence strategies.
The ability to breach an intact mucosal barrier and cause an invasive bloodstream infection 
in humans is a property that sets typhoidal Salmonella serovars apart from non-typhoidal -
Salmonella serovars associated with gastroenteritis (Keestra-Gounder et al., 2015; Raffatellu 
et al., 2006; Tsolis et al., 2008; Wangdi et al., 2012). Clues regarding the identities of the 
mucosal barrier functions limiting the dissemination of the non-typhoidal S. Typhimurium in 
individuals with an intact immune system can be gleaned by analyzing the immune defects 
that put patients at risk of developing bacteremia. Chronic granulomatous disease, which is 
caused by deficiencies in genes encoding subunits of the phagocyte NADPH oxidase (the 
enzyme that generates superoxide radicals during the respiratory burst of phagocytes [Hohn 
and Lehrer, 1975; McPhail et al., 1977; Moellering and Weinberg, 1970; Seger et al., 1983]), 
renders individuals susceptible to develop non-typhoidal Salmonella bacteremia 
(Winkelstein et al., 2000). Thus, the generation of reactive oxygen species (ROS) by 
phagocytes is essential for maintaining an intact mucosal barrier impeding S. Typhimurium 
dissemination beyond the mesenteric lymph node in humans. Whereas the phagocyte 
respiratory burst helps prevent S. Typhimurium dissemination in individuals with an intact 
immune system, S. Typhi and S. Paratyphi A are able to cross an intact mucosal barrier and 
spread from the mesenteric lymph node via the circulation to internal organs. A supposition 
from these observations is that S. Typhi and S. Paratytphi A must possess virulence 
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mechanisms for averting the respiratory burst of human phagocytes, but these virulence 
mechanisms must be absent from S. Typhimurium.
A DNA region present in S. Typhi but absent from the S. Typhimurium genome is the viaB 
locus, which contains genes for the regulation (tviA), synthesis (tviBCDE), and export 
(vexABCDE) of the Vi antigen (Liston et al., 2016; Virlogeux et al., 1995; Wetter et al., 
2012). TviA activates genes involved in Vi antigen synthesis and export while repressing 
genes encoding flagella and the invasion-associated type III secretion system (Winter et al., 
2010, 2009). The latter reduces the generation of inflammatory responses during the 
invasion of the intestinal mucosa (Raffatellu et al., 2007; Winter et al., 2008, 2015, 2014). 
More important, acquisition of the viaB locus by horizontal gene transfer helps explain why 
S. Typhi is able to avert the respiratory burst of neutrophils (Kossack et al., 1981; Miller et 
al., 1972). When a neutrophil comes within close proximity of S. Typhimurium, it migrates 
toward the intruder by following a chemotactic gradient of complement component 5 
fragment a (C5a) that emanates from the bacterial surface (Wangdi et al., 2014). C5a is a 
neutrophil chemoattractant that triggers Rac-dependent NADPH oxidase activation (Bokoch, 
1995), thereby rendering the S. Typhimurium-induced neutrophil oxidative burst 
complement dependent. The Vi antigen encoded by the S. Typhi viaB locus prevents 
complement activation and C5a-mediated neutrophil chemotaxis (Wangdi et al., 2014).
However, the viaB locus is not present in S. Paratyphi A (McClelland et al., 2004), which is 
puzzling because host responses elicited by this pathogen are more similar to those triggered 
by S. Typhi than those observed during S. Typhimurium infection. Here, we resolve this 
apparent paradox by showing that typhoidal Salmonella serovars acquired virulence traits for 
averting the phagocyte respiratory burst through convergent evolution.
RESULTS
Typhoidal Salmonella Serovars Evade the Phagocyte Respiratory Burst
To test the hypothesis that unlike non-typhoidal Salmonella serovars, typhoidal Salmonella 
serovars possess virulence mechanisms for averting the phagocyte respiratory burst, we 
infected human neutrophil-like (HL-60) cells with typhoidal and non-typhoidal Salmonella 
serovars and monitored the generation of ROS using a luminol-based bioassay. Infection 
with non-typhoidal Salmonella serovars, including S. Typhimurium (strains from the 
American Type Culture Collection [ATCC]: ATCC14028 and ATCC7823) and S. Enteritidis 
(strain SSU7998), triggered a robust respiratory burst (Figures 1A and 1B; Figure S1A). In 
contrast, infection of HL-60 cells with typhoidal Salmonella serovars, including S. Typhi 
strain ATCC700931 (Ty2) or S. Paratyphi A strain ATCC9150, did not elicit this response 
(Figures 1A and 1B). Similar results were obtained using primary human neutrophils 
(Figures S1B and S1C).
The Vi Antigen Enables S. Typhi to Avert the Phagocyte Respiratory Burst
To assess whether averting the phagocyte respiratory burst is a feature that is conserved 
among S. Typhi isolates, HL-60 cells were infected with S. Typhi strains Ty2, ATCC19430, 
and ATCC33458. Similar to S. Typhi strain Ty2, S. Typhi strain ATCC19430 did not elicit 
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marked ROS production in HL-60 cells. However, robust ROS production was observed with 
S. Typhi strain ATCC33458 (Figure S1A). The Vi antigen of S. Typhi has been implicated in 
averting the neutrophil respiratory burst (Kossack et al., 1981; Miller et al., 1972), and its 
biosynthesis is encoded by the viaB locus on Salmonella pathogenicity island (SPI) 7, a 
DNA region that can be lost upon laboratory passage of clinical isolates (Bueno et al., 2004; 
Nair et al., 2004). Interestingly, production of the Vi antigen could be detected by dot blot 
analysis in S. Typhi strains Ty2 and ATCC19430, but not in S. Typhi strain ATCC33458 
(Figure S1D). These data suggested that robust ROS production elicited by S. Typhi 
ATCC33458 (Figure S1A) may result from the inability of the strain to produce the Vi 
antigen (Figure S1D). To test this idea, we compared ROS production elicited by S. Typhi 
strain Ty2 in HL-60 cells with that elicited by an isogenic mutant carrying a precise deletion 
of the Vi capsule biosynthesis genes (S. Typhi ΔtviB-vexE mutant). Unlike S. Typhi strain 
Ty2, the non-capsulated S. Typhi ΔtviB-vexE mutant elicited robust ROS production in 
HL-60 cells (Figures 1C and 1D). Similar results were obtained using primary human 
neutrophils (Figures S1E and S1F). Introduction of a plasmid (pDC5) carrying the cloned 
viaB region into the S. Typhi ΔtviB-vexE mutant restored synthesis of the Vi antigen (Figure 
S1G) and moderated ROS production in HL-60 cells (Figures 1E and 1F).
Next, we characterized the mechanism through which the Vi antigen inhibits the neutrophil 
respiratory burst. The Vi antigen inhibits complement activation on the bacterial surface 
(Looney and Steigbigel, 1986; Wilson et al., 2011), thereby conferring serum resistance on 
S. Typhi (Figures 2A and 2B; Figure S1H) (Hart et al., 2016). We investigated whether 
preventing complement activation would inhibit the phagocyte respiratory burst. ROS 
production triggered by infecting HL-60 cells with the non-capsulated S. Typhi ΔtviB-vexE 
mutant was complement dependent because it required opsonization with human serum 
(data not shown) and could be blunted by treatment with Futhan (6-amidino-2-naphthyl p-
guanidinobenzoate dimethanesulfonate; BD Biosciences), a complement inhibitor (Figures 
2C and 2D). The main conduit of lipopolysaccharide (LPS)-mediated complement activation 
in an immunologically naive host is mediated by binding of B-1 cell-derived natural 
immunoglobulin (Ig)M to the bacterial surface, which leads to complement activation 
through the classical pathway (Reid et al., 1997). We thus determined whether IgM in 
human serum binds to purified LPS or to purified Vi antigen. Human IgM bound to LPS 
purified from S. Typhimurium or an S. Typhi ΔtviB-vexE mutant, but it did not bind to 
purified Vi antigen (Figure 2E). We next investigated whether production of Vi antigen 
would prevent IgM binding to the bacterial surface. After incubation of bacteria in human 
serum, proteins bound to the surface were eluted using glycine and analyzed by western blot 
with anti-IgM antibody. Human IgM bound to the surface of S. Typhimurium (ATCC14028) 
and S. Enteritidis (SSU7998), but not to S. Typhi (Ty2). Inhibition of IgM binding to the 
surface of S. Typhi was mediated by the capsular polysaccharide because binding of IgM 
was detected at the surface of an S. Typhi ΔtviB-vexE mutant (Figure 2F), which was 
consistent with a previous report (Hart et al., 2016).
S. Typhi carries a loss-of-function mutation in fepE (Bravo et al., 2008), encoding the length 
regulator of very long O antigen chains (Murray et al., 2003). Because human IgM bound to 
purified S. Typhi LPS (Figure 2E), we investigated whether restoring the expression of very 
long O antigen chains in S. Typhi would result in IgM binding to the bacterial surface. 
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Interestingly, introduction of a plasmid (pTW134) carrying the cloned fepE gene from S. 
Paratyphi A into S. Typhi resulted in the expression of very long O antigen chains (Figure 
S2A) and the binding of human IgM to the bacterial surface (Figure S2B), suggesting that 
the Vi antigen cannot prevent the binding of IgM to very long LPS species. These data were 
consistent with a previous report, showing that lack of very long O antigen chains is required 
for Vi antigen-mediated evasion of complement activation in S. Typhi (Crawford et al., 
2013).
Very Long O Antigen Chains of S. Paratyphi A Inhibit the Phagocyte Respiratory Burst
To investigate the mechanism by which S. Paratyphi A averts the neutrophil respiratory 
burst, we incubated S. Typhimurium (ATCC14028) and S. Paratyphi A (ATCC9150) in 
human serum and analyzed proteins eluted from the bacterial surface (Figure S3A) by mass 
spectrometry (MS) (Figure S3B). The results showed that increased amounts of IgM and 
complement components were eluted from the surface of S. Typhimurium compared to S. 
Paratyphi A (Figure S3). Similarly, S. Typhi bound less IgM and complement components 
compared to S. Typhimurium (Figure S3). However, S. Paratyphi A reduced binding of IgM 
and deposition of complement through a mechanism that did not require the Vi antigen, 
because the biosynthesis of this capsular polysaccharide is encoded by the viaB locus 
(Liston et al., 2016; Virlogeux et al., 1995; Wetter et al., 2012), a DNA region present in S. 
Typhi but absent from S. Paratyphi A (Figure 2E) (McClelland et al., 2004).
Next, we investigated whether evasion of the neutrophil respiratory burst was a general 
feature of S. Paratyphi A isolates. To this end, HL-60 cells were infected with S. Paratyphi A 
var. Durazzo strain ATCC11511 and S. Paratyphi A strains ATCC9150 and ATCC9281. 
ROS production was blunted in HL-60 cells infected with S. Paratyphi A strains ATCC9150 
and ATCC9281, but S. Paratyphi A var. Durazzo strain ATCC11511 elicited a robust 
respiratory burst (Figures 3A and 3B). The latter isolate was first described in a 1934 article 
cautioning that laboratory passage may have begun to alter the O antigen of S. Paratyphi A 
var. Durazzo toward a rough form (Kauffmann and Silberstein, 1934). Dot blot analysis of 
purified LPS suggested that the O2 antigen, which is characteristic of S. Paratyphi A O 
antigen repeat units, was produced by all three isolates (Figure 3C). However, comparison of 
LPS chain lengths revealed that S. Paratyphi A var. Durazzo (ATCC: 11511) lacked very 
long O antigen chains, whereas very long O antigen chains were present in other S. 
Paratyphi A isolates (Figure 3D).
O antigen chains of Salmonella LPS typically exhibit a trimodal length distribution, 
including short LPS species containing between 1 and 15 O antigen repeat units, long LPS 
species carrying between 16 and 35 O antigen repeat units, and very long LPS species with 
>100 O antigen repeat units (Batchelor et al., 1992, 1991; Murray et al., 2003) (Figure 3D). 
A length regulator encoded by the fepE gene controls the synthesis of very long O antigen 
chains (Murray et al., 2003). Inspection of the genomic sequence revealed that the fepE gene 
was disrupted in S. Paratyphi A var. Durazzo (ATCC11511) by a frameshift mutation (i.e., 
insertion of an adenine nucleotide) in position 33 of the open reading frame. In contrast, the 
fepE gene was intact in the other S. Paratyphi A isolates. These data raised the possibility 
that very long O antigen chains of S. Paratyphi A prevented the generation of the phagocyte 
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respiratory burst. Remarkably, inactivation of the fepE gene in S. Paratyphi A strain 
ATCC9150 resulted in the loss of very long O antigen production (Figure 3E) and the 
generation of a robust respiratory burst (Figures 3F and 3G), whereas complementation of 
the mutation via the introduction of a plasmid (pTW134) carrying the cloned fepE gene 
restored the inhibition of ROS production in HL-60 cells. The S. Paratyphi A ATCC9150 
fepE mutant also exhibited increased serum sensitivity compared to the wild-type or a 
complemented mutant (Figure S4). Introduction of a plasmid encoding an intact fepE gene 
(pTW134) into S. Paratyphi A var. Durazzo (ATCC11511) restored very long O antigen 
production (Figure 3H), restored serum resistance (Figure S4A), and abrogated ROS 
production in HL-60 cells (Figures 3I and 3J) and primary human neutrophils (Figures S4B 
and S4C). These data provided direct support for the idea that very long O antigen chains 
enable S. Paratyphi A to avert the phagocyte respiratory burst.
The O2 Antigen of S. Paratyphi A Reduces Antibody-Mediated ROS Production
Studies with normal human serum (NHS) from different individuals suggested that IgM 
binds to LPS purified from S. Typhimurium and S. Typhi, but binding to LPS purified from 
S. Paratyphi A was observed in only a fraction of individuals (Figure 2E; Figure S5). The 
occasional presence of IgM antibodies against S. Paratyphi A LPS in NHS may be the result 
of previous exposure to related antigens in the respective donors. However, the absence of 
IgM binding in a fraction of NHS samples suggested that natural antibodies did not 
recognize S. Paratyphi A LPS. Increased IgM binding to the surface of an S. Paratyphi A 
(ATCC9150) fepE mutant (Figure 4A) suggested that very long O antigen chains reduced 
IgM binding to the bacterial surface.
The O antigen of S. Paratyphi A is composed of an α-D-mannose-(1,4)-α-L-rhamnose-(1,3)-
α-D-galactose backbone (the O12 antigen) and a branching paratose residue that is α-(1,3)-
linked to D-mannose in the backbone (the O2 antigen). O antigens of S. Typhimurium and S. 
Typhi have an identical trisaccharide backbone (the O12 antigen), but they carry abequose 
(the O4 antigen) or tyvelose (the O9 antigen), respectively, as branching sugars. 
Interestingly, rfbE is a pseudogene (i.e., an open reading frame disrupted by a mutation) in 
S. Paratyphi A (Figure 4B) (McClelland et al., 2004), which prevents conversion of cytidine 
diphosphate (CDP)-paratose to CDP-tyvelose and accounts for the presence of paratose (the 
O2 antigen) in place of tyvelose (the O9 antigen), the only structural difference between the 
O antigens of S. Paratyphi A and S. Typhi.
To determine whether the branching paratose residue (the O2 antigen) was necessary for 
inhibiting ROS production, we introduced the S. Typhi rfbE gene into S. Paratyphi A 
(ATCC9150). The resulting S. Paratyphi A strain, henceforth referred to as S. Paratyphi 
AO9, produced very long O antigen chains (Figure 4C) containing the O9 antigen instead of 
the O2 antigen (Figure 4D), which resulted in a robust induction of ROS production in 
HL-60 cells (Figures 4E and 4F) and primary human neutrophils (Figures S4D and S4E). 
Next, we replaced the S. Paratyphi A (ATCC9150) rfbS and rfbE genes, encoding paratose 
synthase and tyvelose epimerase, respectively, with the S. Typhimurium rfbJ gene, encoding 
abequose synthase (Figure 4B). The resulting S. Paratyphi A strain, henceforth referred to as 
S. Paratyphi AO4, produced very long O antigen chains (Figure 5A) containing the O4 
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antigen instead of the O2 antigen (Figure 5B); this resulted in robust ROS production in 
HL-60 cells (Figures 5C and 5D) and primary human neutrophils (Figures S4D and S4E). 
Collectively, these data supported the idea that the O2 antigen is necessary for averting the 
neutrophil respiratory burst.
Human IgM bound to LPS purified from S. Paratyphi AO4 but not to LPS purified from S. 
Paratyphi A (ATCC9150), suggesting that the O2 antigen was responsible for poor binding 
of human natural antibodies to LPS (Figure 5E). Interestingly, S. Paratyphi A opsonized 
with the serum of germ-free mice elicited robust ROS production in murine primary 
neutrophils, suggesting that unlike human natural antibodies, the natural antibody repertoire 
of mice recognizes the O2 antigen (Figures S4F and S4G). We then investigated the binding 
of human IgM to the bacterial surface. Human IgM bound to the surface of S. Paratyphi AO4 
and Paratyphi AO9, but binding to the surface of S. Paratyphi A was reduced markedly in 
comparison (Figure 5F).
Next, we tested whether antibody-mediated complement activation through the classical 
pathway was responsible for the phagocyte respiratory burst triggered by S. Paratyphi AO4. 
Blocking the classical and the alternative pathways of complement activation with EGTA 
abrogated ROS production elicited by S. Paratyphi AO4 in HL-60 cells. Interestingly, 
selective inhibition of the classical pathway with EGTA and Mg2+ (Des Prez et al., 1975) 
resulted in a marked reduction of ROS production (Figure 6A). Similarly, the classical 
pathway was responsible for ROS production elicited by a fepE mutant of S. Paratyphi A 
strain ATCC9150 (Figure S6A), although IgM did not bind LPS purified from this strain 
(Figure S6B). To further investigate the contribution of antibodies to the triggering of the 
phagocyte respiratory burst, we depleted IgM or IgG from NHS. IgM depletion, but not IgG 
depletion, reduced the concentration of IgM in NHS (Figure 6B). Opsonization with IgM-
depleted serum lowered ROS production triggered by S. Paratyphi AO4 in HL-60 cells to 
levels observed with its S. Paratyphi A parent strain (Figure 6C). In contrast, S. Paratyphi 
AO4 opsonized with IgG-depleted serum triggered significantly larger ROS production in 
HL-60 cells than the S. Paratyphi A parent strain. Collectively, these data provided 
compelling support for the idea that the O2 antigen averts the neutrophil respiratory burst in 
a fraction of individuals by preventing IgM binding.
DISCUSSION
The viaB locus is a DNA region acquired by horizontal gene transfer that is present 
exclusively in Salmonella serovars associated with extraintestinal disease, including two 
human-adapted typhoidal Salmonella serovars, S. Typhi and S. Paratyphi C (Selander et al., 
1990), and the bovine-adapted S. Dublin, which causes bacteremia in cattle (Selander et al., 
1992). The presence of the viaB locus confers some of the properties that distinguish S. 
Typhi from non-typhoidal Salmonella serovars associated with human gastroenteritis, such 
as S. Typhimurium (Keestra-Gounder et al., 2015; Raffatellu et al., 2006; Tsolis et al., 2008; 
Wangdi et al., 2012). However, the viaB locus is absent from S. Paratyphi A, which is 
puzzling because paratyphoid fever is indistinguishable in its symptoms from typhoid fever.
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S. Paratyphi A evolved from an ancestral organism producing the O9 -antigen through a 
loss-of-function mutation in rfbE, resulting in expression of the O2 antigen instead of the O9 
antigen (McClelland et al., 2004). Here, we show that very long O antigen chains carrying 
the O2 antigen do not trigger the neutrophil respiratory burst in humans because they prevent 
antibody binding, at least in a fraction of individuals. By analogy, S. Typhi covers its surface 
with the Vi antigen, which does not trigger the neutrophil respiratory burst by preventing 
antibody binding (Hart et al., 2016). In an immunologically naive host, binding of natural 
IgM to the bacterial surface activates complement through the classical pathway (Reid et al., 
1997), which appeared to be the main pathway leading to ROS production in neutrophils 
infected with non-capsulated S. Typhi or S. Paratyphi A lacking very long O antigen chains. 
The picture emerging from this and previous work is that polysaccharide chains can prevent 
complement-dependent ROS production, if they (1) do not bind natural IgM and (2) are long 
enough to prevent pentameric IgM molecules from gaining access to other potential binding 
sites at the bacterial surface (Figure 7). In support of this idea, the presence of very long O 
antigen chains can interfere with immune evasion by the Vi antigen (Crawford et al., 2013), 
presumably because the former rival the capsule in length, thereby exposing IgM binding 
sites at the bacterial surface (Figures 7A–7C). Furthermore, short and long O antigen chains 
produced by an S. Paratyphi A fepE mutant did not bind IgM, but this was not sufficient for 
preventing ROS production, presumably because very long O antigen chains are the only 
surface structures long enough to cover up other IgM binding sites (Figures 7D and 7E). 
These results suggested that S. Typhi and S. Paratyphi A both used very long polysaccharide 
chains to prevent human IgM binding, complement activation, and ROS production, a shared 
virulence strategy that distinguishes them from non-typhoidal Salmonella serovars 
associated with human gastroenteritis. This remarkable example of convergent evolution was 
not apparent from previous work focusing on horizontal gene transfer of the viaB locus, but 
it becomes apparent only when the contribution of pseudogene formation is taken into 
account. This situation is reminiscent of that observed during the evolution of Yersinia pestis 
from a Yersinia pseudotuberculosis-like ancestor, which involved a combination horizontal 
gene transfer (ymt and pla) and pseudogene formation (ureD, rcsA, pde2, and pde3) to 
complete the transition from a gastrointestinal pathogen to an arthropod-borne extraintestinal 
pathogen (Hinnebusch et al., 2016). Recent work suggests that the transition from a 
gastrointestinal to an extraintestinal pathogen involved deletion of genes encoding a pathway 
for anaerobic b-oxidation of butyrate in S. Typhi and S. Paratyphi A, which moderates 
intestinal inflammation during typhoid and paratyphoid fever (Bronner et al., 2018).
Interestingly, whereas the O2 antigen prevented binding of human natural antibodies (Figure 
5), it did not prevent opsonization with serum from germ-free mice (Figures S4F and S4G). 
These data indicate that unlike the natural antibody reservoir of humans, the natural antibody 
reservoir of mice recognizes the O2 antigen. The O2 antigen also is present in a small 
number of non-typhoidal serovars, including S. Nitra, S. Kiel, and S. Koessen (Grimont and 
Weill, 2007), that are not commonly isolated from patients or animals bred as food (Edwards 
et al., 1948; Hargrett-Bean et al., 1988; Rigney et al., 2004). These epidemiological 
observations suggest that S. Nitra, S. Kiel, and S. Koessen are not adapted to humans, but 
they may circulate in an unknown wild animal reservoir.
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EXPERIMENTAL PROCEDURES
Bacterial Strains, Plasmids, and Growth Conditions
Bacterial strains used in this study are presented in Table S1. Bacterial cultures were 
routinely incubated with aeration at 37°C in Luria-Bertani (LB) broth (10 g tryptone, 5 g 
yeast extract, and 10 g NaCl/L) or on LB agar plates unless indicated otherwise. Antibiotics 
were added as appropriate. To induce expression of Vi capsule polysaccharide, low sodium 
(0.25% NaCl) was used to preculture bacterial strains.
S. Paratyphi A strain TWS110 (ΔrfbSE∷rfbJSTM) was generated by replacing the rfbSE 
genes with the rfbJ gene from S. Typhimurium via homologous recombination. Briefly, the 
S. Typhimurium rfbHJ region was amplified with primers 83/84 (Table S2). S. Paratyphi A 
rfbX was amplified with primers 85/86. The two fragments were ligated in tandem and were 
cloned into plasmid pRDH10 using the Gibson Assembly kit (New England Biolabs). The 
construct was transformed into Escherichia coli S17λpir cells. The resulting donor strain 
(TWE76) was conjugated with wild-type S. Paratyphi A to generate strain TWS110 
(ΔrfbSE∷rfbJSTM).
To generate strain TWS159 (S. Paratyphi A 9150 ΔfepE∷KanR), fepE flanking regions 1 and 
2 were amplified from S. Paratyphi A 9150 with primers 133/134 and 135/136, respectively. 
The two fragments were ligated in tandem and were cloned into plasmid pRDH10 using the 
Gibson Assembly kit. The construct was transformed into E. coli S17λpir cells. The 
resulting plasmid (pTW93) was isolated and digested at the engineered BamHI restriction 
site located between flanking regions 1 and 2. A kanamycin-resistance cassette was inserted 
and the plasmid (pTW117) was transformed into E. coli S17λpir cells. E. coli S17λpir 
(pTW117) was conjugated with S. Paratyphi A 9150 carrying a temperature-sensitive 
plasmid pSW172 that conferred carbenicillin resistance for counter selection. An 
exconjugant was cured of pSW172 to generate strain TWS159. To complement the 
mutation, fepE was amplified from S. Paratyphi A 9150 with primers 179/180 and was 
inserted into pWSK29.
To generate an S. Paratyphi A strain producing the O9 antigen (S. Paratyphi A 9150 
ΔrfbE∷rfbESTY), rfbE-flanking regions 1 and 2 were amplified from S. Paratyphi A 9150 
with primers 171/172 and 173/174, respectively. The two fragments were ligated in tandem 
and were cloned into plasmid pRDH10 using the Gibson Assembly kit. The resulting 
plasmid (pTW126) was digested with BamHI to insert a kanamycin-resistance cassette to 
generate plasmid pTW131. E. coli S17λpir (pTW131) was conjugated with S. Paratyphi A 
9150 (pSW172). An exconjugant was cured of pSW172 to generate S. Paratyphi A 9150 
ΔrfbE (HH121). Next, rfbE and its two flanking regions were amplified from S. Typhi with 
primers 86/87. The fragment was inserted into pRDH10 to generate plasmid pTW131. E. 
coli S17λpir (pTW131) was conjugated with HH121 to generate strain HH122 (S. Paratyphi 
A 9150 ΔrfbE∷rfbESTY).
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LPS Analysis
LPS was purified from overnight cultures of bacterial strains using hot-aqueous phenol 
extraction (Davis and Goldberg, 2012). A sensitive silverstaining protocol (Tsai and Frasch, 
1982) was then used for detection of purified LPS separated by SDS-PAGE.
Animal Experiments
All of the experiments in this study were approved by the Institutional Animal Care and Use 
Committee at the University of California, Davis. Germ-free Swiss-Webster mice were bred 
in-house. Femurs collected from germ-free mice after euthanasia were used to isolate 
neutrophils.
Isolation of Primary Neutrophils
The University of California, Davis institutional review board approved the protocol for 
obtaining blood draws for this study. Human neutrophils were isolated from the peripheral 
blood of healthy adult donors using a procedure described previously (Lee et al., 2015).
To collect murine primary neutrophils, mice were euthanized and femurs were collected. 
Neutrophils were then isolated from bone marrow cell suspension using the EasySep mouse 
neutrophil enrichment kit (StemCell Technologies) in accordance with the manufacturer’s 
instructions.
Serum Sensitivity Test
Bacterial cultures were resuspended and adjusted to optical density (OD) 0.1 in PBS. A total 
of 180 μL of cultures were then dispensed into each well of a 96-well plate, containing 20 
μL of undiluted human serum. Plates were incubated at room temperature with gentle 
agitation for 3 hr. At each time point, 20-μL samples were collected, and the bacterial 
numbers were enumerated. As an alternative method, bacteria were incubated with 20% 
serum for 3 hr. Then, 10 μL of undiluted or 10−2 and 10−4 diluted samples were spotted on 
an LB plate and incubated at 37°C overnight and images captured (BioSpectrum Imaging 
System, UVP).
Sequence Analysis
The following reference genomes were used in this study: S. Typhi Ty2 (GenBank: 
AE014613.1), S. Paratyphi A 9150 (GenBank: CP000026.1), S. Typhimurium LT2 
(GenBank: AE006468.2), and S. Paratyphi A var. Durazzo 11511 gene (GenBank: 
CP019185.1). To verify the S. Paratyphi A 11511 fepE nucleotide sequence, the gene was 
amplified with primers 137/138 and cloned into plasmid PCR2.1 to yield pTW128. For 
amino acid sequence alignment, Clustal Omega (https://www.ebi.ac.uk/Tools/msa/clustalo) 
was used.
ROS Assay
ROS production by HL-60 cells or primary neutrophils was measured using 
chemiluminescence. HL-60 cells were differentiated into neutrophil-like cells by incubation 
with RPMI 1640 medium (Thermo Fisher Scientific) containing 1.3% DMSO (Sigma), 15% 
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fetal bovine serum (FBS, Thermo Fisher Scientific) and 25 mM HEPES ((4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid), Thermo Fisher Scientific) for 5–6 days. 
Differentiated HL-60 cells or primary neutrophils were washed and resuspended in phenol 
red free RPMI 1640 containing 2% FBS and luminol (Sigma) was added (1 mM). 
Approximately 5 × 104 HL-60 cells in 90 μL were seeded into an opaque 96-well microplate 
(Perkin-Elmer) and the basal luminescence was measured every 2 min for 5 min on a 
FilterMax F3 plate reader (Molecular Devices). HL-60 cells were infected with 10 μL of 
bacteria (MOI = 10) opsonized with 20% human serum (30 min at room temperature) or 
were mock treated, and ROS production was measured every 2 min using a plate reader. In 
some experiments, human serum was treated with Futhan, 10 mM EGTA, or 10 mM Mg2+ 
plus 10 mM EGTA (MgEGTA) before opsonizing bacteria.
Dot Blot Assay
LPS was purified using an LPS extraction kit (iNtRON Biotechnology). Vi capsule 
polysaccharide was purified essentially as described for capsular polysaccharides from 
Bacteroides fragilis (Pantosti et al., 1991). Briefly, frozen cell pellets of S. Typhi strain Ty2 
were lysed and extracted with 37% phenol (Sigma) in water at 68°C with vigorous agitation. 
The aqueous phase was collected and extracted with ethyl ether (Thermo Fisher Scientific) 
to remove the remaining phenol, and the ether was removed from the aqueous phase on a 
rotary evaporator (BUCHI) at 60°C for 2 hr. DNA and RNA were eliminated from the 
sample by DNase and RNase (both Worthington Biochemical) digestion, respectively, and 
protein removed by serial digests with Pronase (Calbiochem). Polysaccharide was then 
harvested by ethanol precipitation and separated from LPS on a Sephacryl S300 (GE 
Healthcare) column in 3% deoxycholate (Sigma).
Purified LPS at 5 μL or Vi capsule polysaccharide (100 μg/mL) were spotted onto a 
nitrocellulose membrane and air dried. The membrane was blocked with 5% skim milk in 
PBS-T (PBS containing 0.25% Tween 20). To detect specific O antigens or Vi capsule 
polysaccharide, we used anti-O2, -O4, -O9, or anti-Vi capsule polysaccharide polyclonal 
antibodies (BD Biosciences), respectively, and secondary horseradish peroxidase (HRP)-
anti-rabbit Ig. To assess IgM binding to LPS or Vi capsule polysaccharide, the membrane 
was incubated with diluted (1/1000–1/5000) human serum overnight at 4°C. Bound IgM was 
detected using HRP-anti-human IgM (Jackson ImmunoResearch). Enhanced 
chemiluminescence (ECL; PerkinElmer) was used to develop, and images were obtained on 
an imager (BioSpectrum Imaging System, UVP).
IgM Binding
To assess human IgM binding to the surface of bacterial cells, 1 × 109 colony-forming units 
(CFUs) of the indicated bacterial strains were incubated with 500 μL of 20% NHS (heat 
inactivated) or PBS for 1 hr at room temperature. After washing the bacteria with PBS four 
times, bound serum proteins were eluted by resuspending the samples in 100 μL of 0.1 M 
glycine-HCl followed by centrifugation. A total of 80 μL supernatants were collected and 
subsequently neutralized with 20 μL of 1 M (tris(hydroxymethyl)aminomethane) (Tris)-HCl 
buffer (pH 8.0). Neutralized samples and bacterial pellets were precipitated with methanol-
chloroform and resuspended with Laemmli sample buffer. Samples were subjected to 10% 
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SDS-PAGE gel. After electrotransfer, the polyvinylidene fluoride (PVDF) membranes 
(Merck Millipore) were probed with HRP-conjugated anti-human IgM antibody (Jackson 
ImmunoResearch). As an internal control, bacterial pellets were separated by SDS-PAGE, 
blotted onto PVDF, and probed with anti-GroEL (Sigma). The blots were developed using 
ECL (PerkinElmer), and images were obtained on an imager (BioSpectrum Imaging System, 
UVP).
MS
Proteins eluted from the bacterial surface were analyzed by MS. Briefly, 5 × 108 CFU of 
bacteria were incubated with 500 μL of 20% NHS, heat-inactivated 20% NHS, or PBS for 
40 min at room temperature. Bacterial pellets were spun down and washed with PBS four 
times. Bound serum proteins and some bacterial proteins were eluted in 100 μL of 0.1 M 
glycine-HCl (pH 2.7). Supernatants (80 μL) were neutralized by adding 20 μL of 1 M Tris 
(pH 8.0). Samples were then precipitated using methanol-chloroform. The precipitated 
pellets were resuspended in 60 μL SDS-sample buffer and purified by PAGE followed by 
MS analysis by the Proteomics Core Facility at the University of California, Davis Genome 
Center.
Statistical Analysis
All of the data are expressed as the mean and standard error of the mean. Student’s t tests 
were used for statistical analyses. p < 0.05 was considered significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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In Brief
The clinical presentation of typhoid fever differs from gastroenteritis, which has been 
attributed to the Salmonella enterica serovar (S.) Typhi capsular polysaccharide. 
Paradoxically, S. Paratyphi A is not capsulated but causes typhoid-like disease. Hiyoshi 
et al. show that the very long O antigen of S. Paratyphi A functions as a capsule, an 
example of convergent evolution.
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Highlights
• Typhoidal but not non-typhoidal Salmonella serovars foil the PMN respiratory 
burst
• The Vi antigen averts binding of natural antibodies to foil the PMN 
respiratory burst
• S. Paratyphi A very long O antigen chains foil the PMN respiratory burst
• Virulence in typhoidal Salmonella serovars arose through convergent 
evolution
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Figure 1. S. Typhi Evades the Respiratory Burst in Neutrophil-like Cells Using the Vi Antigen
HL-60 cells were infected with the indicated opsonized bacterial strains and ROS production 
monitored over time using chemiluminescence.
(A and B) HL60 cells were infected with the indicated Salmonella serovars.
(C and D) HL60 cells were infected with capsulated and non-capsulated S. Typhi strains.
(E and F) HL60 cells were infected with S. Typhi wild type, a tviB-vexE mutant and a tviB-
vexE mutant complemented by introducing the viaB locus on a plasmid (pDC5).
(A, C, and E) Representative experiment showing generation of chemiluminescence over 
time.
(B, D, and F) Quantification of chemiluminescence from three independent experiments at 
the indicated time point after infection. Bars represent means ± SE. Mock, mock infection; 
pDC5, XX; RLU, relative luminescence units. *p < 0.05; **p < 0.01.
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Figure 2. The Vi Antigen Averts the Phagocyte Respiratory Burst by Inhibiting Antibody-
Dependent Complement Activation
(A) Viability of the indicated bacterial strains incubated in 10% NHS was monitored over 
time.
(B) Viability of the indicated bacterial strains incubated in PBS, 20% NHS, or 20% NHS 
supplemented with Futhan was determined by spotting serial dilutions on agar plates.
(C and D) HL-60 cells were infected with the indicated opsonized bacterial strains and ROS 
production monitored over time using chemiluminescence.
(C) Representative experiment showing generation of chemiluminescence over time.
(D) Quantification of chemiluminescence from three independent experiments at the 
indicated time point after infection.
(E) Binding of IgM in human serum (α-IgM; top); binding of rabbit anti-Vi antigen serum 
(α-Vi; middle); or binding of rabbit anti-O2, -O4, -O9 serum (α-O2, O4, O9; bottom panel) 
to purified LPS of the indicated bacterial strains or to purified Vi antigen was detected by 
dot blot.
(F) The indicated bacterial strains were incubated in human serum and surface-bound 
proteins eluted with glycine. IgM eluted from the bacterial surface was detected by western 
blot (α-IgM; top). The bacterial protein GroEL was detected in the bacterial pellet (α-
GroEL; bottom) and used as a loading control by measuring the IgM/GroEL using 
densitometry.
(A and D) Bars represent means ± SE.
Mock, mock infection; RLU, relative luminescence units. **p < 0.01.
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Figure 3. Very Long O Antigen Chains of S. Paratyphi A Are Necessary for Evasion of the 
Respiratory Burst in Neutrophil-like Cells
(A and B) HL-60 cells were infected with the indicated opsonized S. Paratyphi A or S. 
Paratyphi A var. Durazzo strains and ROS production monitored over time using 
chemiluminescence.
(C) Production of the O2-antigen was detected in LPS purified from the indicated bacterial 
strains using rabbit anti-O2 serum.
(D) LPS purified from the indicated S. Paratyphi A or S. Paratyphi A var. Durazzo strains 
was separated by SDS-PAGE and silver stained.
(E) LPS purified from S. Paratyphi A strain ATCC9150, an isogenic fepE mutant or a 
complemented fepE mutant was separated by SDS-PAGE and silver stained.
(F and G) S. Paratyphi A strain ATCC9150, an isogenic fepE mutant or a complemented 
fepE mutant were opsonized and ROS production elicited after infection of HL-60 cells 
monitored over time using chemiluminescence.
(H) LPS purified from the indicated S. Paratyphi A var. Durazzo strains was separated by 
SDS-PAGE and silver stained.
(I and J) HL-60 cells were infected with the indicated opsonized S. Paratyphi A var. Durazzo 
strains and ROS production monitored over time using chemiluminescence.
(A, B, F, G, I, and J) HL-60 cells were infected with the indicated opsonized bacterial strains 
and ROS production monitored over time using chemiluminescence.
(A, F, and I) Representative experiments showing generation of chemiluminescence over 
time.
(B, G, and J) Quantification of chemiluminescence from three independent experiments at 
the indicated time point after infection. Bars represent means ± SE. L, long O antigen 
chains; Mock, mock infection; pTW134, plasmid carrying the cloned fepE gene from S. 
Paratyphi A strain ATCC9150; pWSK29, cloning vector; RLU, relative luminescence units; 
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S, short O antigen chains; VL, very long O antigen chains; ; 9150, S. Paratyphi A strain 
ATCC9150; 9281, S. Paratyphi A strain ATCC9281; 11511, S. Paratyphi A var. Durazzo 
strain ATCC11511. **p < 0.01.
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Figure 4. Heterologous Production of the O9 Antigen by S. Paratyphi A Activates the 
Respiratory Burst in Neutrophil-like Cells
(A) The indicated S. Paratyphi A strains were incubated in human serum and surface-bound 
proteins eluted with glycine. IgM eluted from the bacterial surface was detected by western 
blot (α-IgM; top). The bacterial protein GroEL was detected in the bacterial pellet (α-
GroEL; bottom) and used as a loading control by measuring the IgM/GroEL using 
densitometry.
(B) Schematic of the O antigen biosynthesis gene clusters in the indicated Salmonella 
serovars.
(C) LPS purified from the indicated bacterial strains was separated by SDS-PAGE and silver 
stained.
(D) LPS purified from the indicated bacterial strains was loaded on a dot blot to detect 
binding of IgM present in NHS (α-IgM; top), production of the O2 antigen (α-O2; middle), 
or production of the O9 antigen (α-O9; bottom).
(E and F) HL-60 cells were infected with the indicated opsonized bacterial strains and ROS 
production monitored over time using chemiluminescence.
(E) Representative experiment showing generation of chemiluminescence over time.
(F) Quantification of chemiluminescence from four independent experiments at the indicated 
time point after infection. Bars represent means ± SE.
Ψ, pseudogene; L, long O antigen chains; Mock, mock infection; RLU, relative 
luminescence units; S, short O antigen chains; VL, very long O antigen chains. **p < 0.01.
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Figure 5. Heterologous Production of the O4 Antigen by S. Paratyphi A Activates the 
Respiratory Burst in Neutrophil-like Cells
(A) LPS purified from the indicated bacterial strains was separated by SDS-PAGE and silver 
stained.
(B) LPS purified from the indicated bacterial strains was loaded on a dot blot to detect 
production of the O2 antigen (α-O2; top) or production of the O4 antigen (α-O4; bottom).
(C and D) HL-60 cells were infected with the indicated opsonized bacterial strains and ROS 
production monitored over time using chemiluminescence. (C) Representative experiment 
showing generation of chemiluminescence over time.
(D) Quantification of chemiluminescence from four independent experiments at the 
indicated time point after infection. Bars represent means ± SE.
(E) LPS purified from the indicated bacterial strains was loaded on a dot blot to detect 
binding of IgM present in NHS (α-IgM).
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(F) The indicated bacterial strains were incubated in human serum and surface-bound 
proteins eluted with glycine. IgM eluted from the bacterial surface was detected by western 
blot (α-IgM; top). The bacterial protein GroEL was detected in the bacterial pellet (α-
GroEL; bottom) and used as a loading control by measuring the IgM/GroEL using 
densitometry. L, long O antigen chains; Mock, mock infection; RLU, relative luminescence 
units; S, short O antigen chains; SN, supernatant; VL, very long O antigen chains. *p < 0.05.
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Figure 6. Heterologous Production of the O4 Antigen by S. Paratyphi A Activates the 
Respiratory Burst in Neutrophil-like Cells through Antibody-Mediated Complement Activation
(A) HL60 cells were infected with the indicated opsonized bacterial strains and ROS 
production in the presence (+) or absence (-) of EGTA and magnesium (Mg2+) was 
monitored over time using chemiluminescence.
(B) The indicated serum dilutions were applied to a dot blot to detect the presence of IgM 
using anti-human IgM antibody (α-IgM).
(C) HL60 cells were infected with the indicated bacterial strains opsonized with IgG-
depleted serum or IgM-depleted serum and ROS production monitored over time using 
chemiluminescence.
(A and C) Chemiluminescence was quantified from three independent experiments at the 
indicated time point after infection. Bars represent means ± standard error.
Mock, mock infection; NS, not statistically significantly different; RLU, relative 
luminescence units; wt, wild-type. *p < 0.05; **p < 0.001.
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Figure 7. Model for Evasion of the Phagocyte Respiratory Burst by Typhoidal Salmonella 
Serovars
(A) The polysaccharide chains of the Vi antigen shield underlying surface structures from 
IgM binding.
(B) Restoration of the fepE pseudogene (ΨfepE) in S. Typhi results in production of very 
long O antigen chains that rival the Vi antigen in length, thereby elevating IgM binding to 
the bacterial surface.
(C) Deletion of the capsule biosynthesis genes in the S. Typhi tviB-vexE mutant exposes the 
short and long O antigen chains, thereby resulting in IgM binding.
(D) The very long O antigen chains of S. Paratyphi A contain the O2 antigen, which does 
not bind natural IgM, thereby shielding underlying surface structures.
(E) The short and long O antigen chains present in an S. Paratyphi A fepE mutant do not 
bind IgM, but are too short to prevent IgM binding to other surface antigens. Ag, antigens; 
CM, plasma membrane; L, long O antigen chains; OM, outer membrane; S, short O antigen 
chains; Vi, Vi antigen; VL, very long O antigen chains.
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